Form 4: First Tracks Biotherapeutics Director Sells Shares
Insider Transaction (Form 4)
J. Anthony Ware, a Director of First Tracks Biotherapeutics, Inc., sold 39,265 shares of common stock on September 2, 2026 for $44.78 per share.
Summary
- Option exercise/conversion: acquired 39,265 Common Stock at $5.74 ($225,381) on September 2, 2026; holds 54,925 after (Direct).
- Open-market sale: disposed of 39,265 Common Stock at $44.78 ($1,758,145) on September 2, 2026; holds 15,660 after (Direct).
- Option exercise/conversion: disposed of 28,571 Stock Option (right to buy) on September 2, 2026 (Direct).
- Option exercise/conversion: disposed of 10,694 Stock Option (right to buy) on September 2, 2026 (Direct).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $1,758,145 of stock on the open market.
Insider Transactions
J. Anthony Ware — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-02 | Option exercise/conversion | Common Stock | 39,265 | $6 | $225.4K | 54,925 |
| 2026-09-02 | Open-market sale | Common Stock | 39,265 | $45 | $1.8M | 15,660 |
| 2026-09-02 | Option exercise/conversion | Stock Option (right to buy) | 28,571 | — | — | 0 |
| 2026-09-02 | Option exercise/conversion | Stock Option (right to buy) | 10,694 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-02 | Option exercise/conversion (39,265 shares) |
| 2026-09-02 | Open-market sale (39,265 shares) |
| 2026-09-02 | Option exercise/conversion (28,571 shares) |
| 2026-09-02 | Option exercise/conversion (10,694 shares) |
Keywords
insider transaction, Form 4, TRAX, First Tracks Biotherapeutics, Inc., bearish, J. Anthony Ware
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.